National MS Society: Researchers Report Using Novel MRNA 'Vaccine' to Treat Mice With MS-Like Disease - Further Research Needed to Translate to People
January 14, 2021
January 14, 2021
NEW YORK, Jan. 14 -- The National Multiple Sclerosis Society issued the following news:
Investigators at the Johannes Gutenberg University in Mainz, Germany, and colleagues have reported success in reducing inflammation and disease activity in mouse models of MS by injecting messenger RNA that had been manipulated to deliver to the immune system the codes of molecular targets thought to be involved in the development of MS.
The goal is to induce immune tolerance to the . . .
Investigators at the Johannes Gutenberg University in Mainz, Germany, and colleagues have reported success in reducing inflammation and disease activity in mouse models of MS by injecting messenger RNA that had been manipulated to deliver to the immune system the codes of molecular targets thought to be involved in the development of MS.
The goal is to induce immune tolerance to the . . .